A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy

10.9K views

⸱

DOI:

10.3791/57849

⸱

November 29th, 2018

 ,  ,  , 

In This Article

Summary

We introduce a murine orthotopic breast cancer model and radical mastectomy model with bioluminescence technology to quantify the tumor burden to mimic human breast cancer progression.

Abstract

In vivo mouse models to assess breast cancer progression are essential for cancer research, including preclinical drug developments. However, the majority of the practical and technical details are commonly omitted in published manuscripts which, therefore, makes it challenging to reproduce the models, particularly when it involves surgical techniques. Bioluminescence technology allows for the evaluation of small amounts of cancer cells even when a tumor is not palpable. Utilizing luciferase-expressing cancer cells, we establish a breast cancer orthotopic inoculation technique with a high tumorigenesis rate. Lung metastasis is assessed utilizing an ex vivo technique. We, then, establish a mastectomy model with a low local recurrence rate to assess the metastatic tumor burden. Herein, we describe, in detail, the surgical techniques of orthotopic implantation and mastectomy for breast cancer with a high tumorigenesis rate and low local recurrence rates, respectively, to improve breast cancer model efficiency.

Introduction

Animal models play a key role in cancer research. When a hypothesis is proven in vitro, it should be tested in vivo to evaluate its clinical relevance. Cancer progression and metastasis are often better captured by animal models as compared to in vitro models, and it is essential to test a new drug in an animal model as a preclinical study for drug development1,2. However, the technical details of animal experiments are often not well described in published articles, making it challenging to reproduce the model successfully. Indeed, the authors who established these orthotopic inoculation and mastectomy models....

Access restricted. Please log in or start a trial to view this content.

Protocol

Approval from the Roswell Park Comprehensive Cancer Center Institutional Animal Care and Use Committee was obtained for all experiments.

NOTE: Nine to twelve weeks-old female BALB/c mice are obtained. 4T1-luc2 cells, a mouse mammary adenocarcinoma cell line derived from BALB/c mice that has been engineered to express luciferase, are used. These cells are cultured in Roswell Park Memorial Institute (RPMI) 1640 medium with 10% fetal bovine serum (FBS).

1. Preparation of Instruments

  1. Thaw a frozen gelatinous protein mixture (e.g., Matrigel) on ice in a tissue culture hood.
  2. ....

Access restricted. Please log in or start a trial to view this content.

Results

The purpose of the orthotopic model is to mimic human cancer progression (i.e., the growth of the primary tumor followed by lymph node metastasis and then distant lung metastasis)15. After cancer cell inoculation, the bioluminescence is quantified regularly (two to three times/week) (Figure 1A). The bioluminescence in the lungs is deeper and smaller than the primary lesion. The bioluminescence mainly reflects the primary tumor.......

Access restricted. Please log in or start a trial to view this content.

Discussion

For the last decade, we have been establishing multiple murine cancer models, including breast cancer models3,7,13,16,20,21. Previously, we demonstrated that breast cancer cell orthotopic inoculation into the mammary gland tissue under direct vision produced a larger tumor with less size variability compared to injecting cell.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by NIH grant R01CA160688 and Susan G. Komen Foundation Investigator Initiated Research grant (IIR12222224) to K.T. Mice bioluminescence images were acquired by shared resource Translational Imaging Shared Resource at Roswell Park Comprehensive Cancer Center, which was supported by the Cancer Center Support Grant (P30CA01656) and Shared Instrumentation grant (S10OD016450).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Micro Dissection ScissorsRobozRS-5983For cancer cell inoculation and masstectomy
Adson ForcepsRobozRS-5233For cancer cell inoculation and masstectomy
Needle HolderRobozRS-7830For cancer cell inoculation and masstectomy
MayoRobozRS-6873For ex vivo
5-0 silk suturesLook774BFor cancer cell inoculation and masstectomy
Dry sterilant (Germinator 500)Braintree ScientificGER 5287-120VFor cancer cell inoculation and masstectomy
ClipperWahl9908-717For cancer cell inoculation and masstectomy
MatrigelCorning354234For cancer cell inoculation
D-Luciferin, potassium saltGOLD-BioLUCK-1KFor bioluminescence quantification
Roswell Park Memorial Insitute 1640Gibco11875093For cell culture
Fetal Bovine SerubGibco10437028For cell culture
Trypsin-EDTA (0.25%)Gibco25200056For cell culture

References

  1. Rashid, O. M., Takabe, K. Animal models for exploring the pharmacokinetics of breast cancer therapies. Expert Opinion on Drug Metabolism & Toxicology. 11 (2), 221-230 (2015).
  2. Schuh, J. C. Trials, tribulations, and trends in tumor model....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Orthotopic ImplantationMurine MastectomyBioluminescence ImagingLung Metastasis QuantificationCancer Cell InjectionSurgical Board PreparationMammary Fat PadNonabsorbable SuturesD-Luciferin AdministrationEx Vivo Lung Analysis